Marijuana laws: Difference between revisions

From Bhamwiki
Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{stub}}
{{stub}}
==Industrial hemp==
==Industrial hemp==
The [[2016 Alabama Industrial Hemp Research Program Act]] provided a legal distinction between industrial hemp and marijuana within the confines of state-operated research programs.
The [[2016 Alabama Industrial Hemp Research Program Act]] provided a legal distinction between industrial hemp and marijuana within the confines of state-operated research programs. The 2018 federal farm bill legalized the production of industrial hemp outside of sanctioned research projects.


==CBD==
==CBD==
The sale or possession of CBD in Alabama is generally held to be illegal, except for certain exceptions established by law. Relevant statues include the [[2014 Carly's Law]] which provides an "affirmative defense" to people prescribed CBD as part of a study conducted by the [[UAB Department of Neurology]] to treat debilitating epilepsy, and [[2016 Leni's Law]], which expands that defense to any patient prescribed CBD for the treatment of conditions causing chronic or debilitating seizures, and expressly includes the parents or guardians of minors being treated.
Until December 2018, the sale or possession of cannabidiol (CBD) in Alabama was generally held to be illegal, except for certain exceptions established by law. The legalization of industrial hemp cultivation made it effectively legal to produce, sell or posses products containing CBD derived from hemp and containing no more than than 0.3% THC.


Certain regulatory recommendations from federal agencies have been reflected in rules adopted by state agencies, as well. The [[Alabama Department of Public Health]] has allowed the sale of FDA-approved drugs containing CBD under certain conditions.
Relevant statues include the [[2014 Carly's Law]] which provides an "affirmative defense" to people prescribed CBD as part of a study conducted by the [[UAB Department of Neurology]] to treat debilitating epilepsy, and [[2016 Leni's Law]], which expands that defense to any patient prescribed CBD for the treatment of conditions causing chronic or debilitating seizures, and expressly includes the parents or guardians of minors being treated.
 
Certain regulatory recommendations from federal agencies have been reflected in rules adopted by state agencies, as well. The [[Alabama Department of Public Health]] has allowed the sale of FDA-approved drugs containing CBD under certain conditions for the treatment of Lennox-Gastaut syndrome and Dravet syndrome.


==References==
==References==
Line 14: Line 16:
* Taylor, Stephanie (October 10, 2018) "Tuscaloosa drug task force targets sale of CBD oil." {{TN}}
* Taylor, Stephanie (October 10, 2018) "Tuscaloosa drug task force targets sale of CBD oil." {{TN}}
* Cason, Mike (November 20, 2018) "Cannabidiol still illegal; Alabama AG explains narrow exceptions." {{BN}}
* Cason, Mike (November 20, 2018) "Cannabidiol still illegal; Alabama AG explains narrow exceptions." {{BN}}
* Cason, Mike (December 12, 2018) "Alabama AG says some CBD from hemp now legal." {{BN}}


[[Category:Laws]]
[[Category:Laws]]

Revision as of 10:26, 13 December 2018

Marijuana laws are state and local laws that prohibit or restrict the cultivation, sale, use, or possession of cannabis sativa, a plant that has been cultivated for industrial uses as well as for its psychoactive properties.

Industrial hemp

The 2016 Alabama Industrial Hemp Research Program Act provided a legal distinction between industrial hemp and marijuana within the confines of state-operated research programs. The 2018 federal farm bill legalized the production of industrial hemp outside of sanctioned research projects.

CBD

Until December 2018, the sale or possession of cannabidiol (CBD) in Alabama was generally held to be illegal, except for certain exceptions established by law. The legalization of industrial hemp cultivation made it effectively legal to produce, sell or posses products containing CBD derived from hemp and containing no more than than 0.3% THC.

Relevant statues include the 2014 Carly's Law which provides an "affirmative defense" to people prescribed CBD as part of a study conducted by the UAB Department of Neurology to treat debilitating epilepsy, and 2016 Leni's Law, which expands that defense to any patient prescribed CBD for the treatment of conditions causing chronic or debilitating seizures, and expressly includes the parents or guardians of minors being treated.

Certain regulatory recommendations from federal agencies have been reflected in rules adopted by state agencies, as well. The Alabama Department of Public Health has allowed the sale of FDA-approved drugs containing CBD under certain conditions for the treatment of Lennox-Gastaut syndrome and Dravet syndrome.

References